Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, briefly discusses how the tumor microenvironment plays a role in resistance to targeted therapies in multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.